HAART Is Shown to Be Safe for Use During Pregnancy

A study in the February edition of the Journal of Acquired Immune Deficiency Syndromes shows that children exposed to antiretroviral drugs in utero as part of efforts to prevent mother-to-child HIV transmission typically do not suffer from perinatal problems or major health events later in life. Antiretroviral therapy was not significantly associated with any pattern or prevalence of congenital abnormalities, low birth weight, or clinical manifestations suggestive of mitrochondrial damage, according to the researchers, who analyzed data from the European Collaborative Study.